key: cord-0888062-k3nolcm0 authors: Mahmoud, Fatma Mohamed; Harhara, Thana title: Neisseria meningitidis pneumonia with bacteremia without meningitis: an atypical presentation date: 2020-07-03 journal: IDCases DOI: 10.1016/j.idcr.2020.e00897 sha: 47791a486cafb9dc69482d917e289d3fc6914c33 doc_id: 888062 cord_uid: k3nolcm0 Neisseria meningitidis remains the most important cause of bacterial meningitis worldwide. The second most common and potentially severe end-organ manifestation of invasive meningococcal disease is meningococcal pneumonia. It occurs between 5% and 15% of all patients with invasive meningococcal disease. N. meningitidis sepsis and meningitis continue to be associated with high morbidity and mortality, however, meningococcal pneumonia is uncommon and often underreported. We describe a case of sepsis secondary to pneumonia with N. meningitidis bacteremia, without any evidence of meningitis. This case reports aims at highlighting pneumonia as a presentation of N. meningitidis bacteremia, and the need for a high level of clinical suspicion to establish the diagnosis. At least 13 serogroups of meningococci have been identified by immunologic specificity of capsular polysaccharides (1) . Transmissibility, invasiveness, and virulence vary The exact incidence of meningococcal pneumonia remains unknown but is estimated to be 5%-15% in patients with invasive meningococcal disease. The mortality in promptly treated meningococcal meningitis is about 2-4%, whereas mortality in septicemia without meningitis is 20-40%. Most deaths occur within the first 24 to 48 hours (1). A 30-year-old previously healthy male presented to the Emergency Department with a 5-day history of productive cough, fever, shortness of breath, and severe pleuritic chest pain. The fever was associated with chills and decreased appetite and was responding partially to over the counter antipyretics. The patient had traveled to India within 4 weeks prior to the presentation. Upon presentation, the patient appeared acutely ill. Vital signs included tachycardia of 112 beats per minute, respiratory rate of 26 breaths per minute, with an oxygen saturation of 94% on room air. Laboratory investigations showed leukocytosis of 32,800/ยต/L with neutrophilia, high procalcitonin of 16.5 ng/mL, and CRP of >300 mg/L. A chest x-ray revealed a right upper lobe patchy consolidation, with no cavitation, associated with prominent perihilar and infrahilar markings. There was no pleural effusion or pneumothorax ( Figure 1 ). The patient was initially admitted as a case of community-acquired pneumonia (CAP). Sputum and blood cultures were collected. Since his illness was during the COVID-19 pandemic, nasopharyngeal swabs were taken to rule out COVID-19 infection. The patient was started on piperacillin-tazobactam and Azithromycin as per local empiric antibacterial guidelines for CAP. Within a day of incubation, the blood culture grew gram-negative diplococci in the aerobic bottles. The final culture results identified Neisseria meningitidis which was sensitive to benzylpenicillin, ceftriaxone, ciprofloxacin, and meropenem, but resistant to trimethoprim-sulfamethoxazole. The antibacterials were initially changed to ceftriaxone 2 grams every 12 hours to cover possible meningitis. However, due to the absence of any risks for meningococcemia and its complications, the antimicrobial dose was decreased to 1 gram of ceftriaxone every 12hrs. The patient denied any headache or neurologic symptoms and was free of any meningeal signs on multiple physical examinations. The patient had no other end-organ complications. Routine liver and renal function laboratory tests were normal and an abdominal ultrasound was unremarkable. HIV testing was negative. Active pulmonary tuberculosis was ruled out with 3 negative Early recognition and treatment are critical as the case fatality rate for N. meningitidis pneumonia has been reported to be higher, as compared with meningococcal meningitis (16% versus 9%-14%) and of equal importance is antibacterial prophylaxis for close contacts of these patients to prevent meningitis or septicemia (6) . Complications of meningococcal pneumonia are uncommon and include septic shock, lung abscess, pleural effusion, and pericarditis (7). Empiric therapy for patients with suspected (e.g. gram stain with gram-negative diplococci) or culture-proven meningococcal infection consists of a third-generation cephalosporin (such as ceftriaxone or cefotaxime given their excellent efficacy, convenient dosing, and affordability. Before 1991, penicillin was the treatment of choice for meningococcal infections (6) , however, with the emergence of penicillin-resistant strains and in the setting of the high mortality associated with invasive meningococcal disease, the empiric treatment recommendation was changed to a third-generation cephalosporin (6) . Alternative drug choices include meropenem (unavailability of a thirdgeneration cephalosporin), chloramphenicol (for severe beta-lactam allergy), aztreonam (if chloramphenicol is unavailable in the case of severe beta-lactam allergy), or a fluoroquinolone, such as moxifloxacin (7, 8) . Despite being an unusual presentation of N. meningitidis, the ability of the meningococcus to cause pneumonia has been appreciated for many years and should always be considered when blood or sputum cultures identify gram-negative diplococci. The diagnosis may be challenging because of the low sensitivity of blood cultures and lack of specificity of the sputum sample because of the carrier status of asymptomatic people (9), however, it remains an important diagnosis to consider, as prompt treatment is required to improve the outcome of meningococcal infections and reduce related morbidity and mortality. Patient's written consent has been obtained before writing and submitting this manuscript The authors of this manuscript have no conflicts of interests Neisseria meningitidis Adelberg's Medical Microbiology. 28th ed. McGraw-Hill Education Invasive meningococcal disease without meningitis: a forgotten diagnosis Meningococcal pneumonia: a review Meningococcal Pneumonia: Characterization and Review of Cases Seen Over the Past 25 Years Meningococcal pneumonia Meningoccocal disease, a clinical and epidemiological review Practice Guidelines for the Management of Bacterial Meningitis